Generic name : Avibactam and Ceftazidime.
Trade name : Avycaz.
Manufacturer information :
Avycaz is manufactured by Actavis.
Avycaz FDA Approval :
Avycaz first approved February 25th, 2015.
Avycaz Dosage form :
Avycaz (Ceftazidime-avibactam) for injection in single-use vials containing 2 grams ceftazidime and 0.5 grams avibatam.
Avycaz Indications and Usage :
Indicated in combination with metronidazole for complicated intra-abdominal infections (cIAIs) caused by escherichia coli, klebsiella pneumoniae, proteus mirabilis, providencia stuartii, enterobacter cloacae, klebsiella oxytoca, and pseudomonas aeruginosa.
Urinary Tract Infections
Indicated for complicated urinary tract infections (cUTIs) including pyelonephritis caused by designated susceptible bacteria, including escherichia coli, klebsiella pneumoniae, citrobacter koseri, enterobacter aerogenes, enterobacter cloacae, citrobacter freundii, proteus spp., and pseudomonas aeruginosa.
Avycaz (Ceftazidime-avibactam) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.